CHEST.

By now I guess that everyone has noted that the enormously important  Diel Metasudy has been published in the latest edition of the CHEST Journal. 

The CHEST Journal is highly influential and Diel commands enormous respect in the TB field.

Acceptance Rate: between 9% and 13% since 2005

Print Circulation: 20,460

2008 Institute of Scientific Information: Journal Citation Report Data:
Impact Factor: 5.154; ranked 4th among 40 Respiratory Journals
Total Citations: 41,112; ranked 2nd among 40 Respiratory Journals
Articles: 388; ranked 3rd among 40 Respiratory Journals
Immediacy Index: 1.430; ranked 3rd among 40 Respiratory Journals
Eigenfactor Score: 0.11173; ranked 2nd among 40 Respiratory Journals
Article Influence Score: 1.516; ranked 5th among 40 Respiratory Journals

Note that this Journal article has been widely disseminated through other sources.  

This study, which determines the absolute superiority of QuantiFERON-TB Gold over all other options for latent TB testing in conjunction with the new CDC Guidelines that are to be published "any day now" places us at what will be regarded in the future as the point where QFT commenced the realization of the potential that we all knew it had.